Blog

Stay up to date with the latest news and standards knowledge.

Blog > Blog

Formedix On Platform Updates: Dec 2018

Formedix On Platform Updates: Sept 2018

Formedix On Platform Updates: June 2018

Cost-benefit Analysis for the Implementation of CDISC Standards During Clinical Trial Setup – Calculating the Break-even Point - Part 2

Cost-benefit Analysis for the Implementation of CDISC Standards During Clinical Trial Setup – Part 1

How to Describe Multiple Origins for a Value in Define-XML 2

Formedix On Platform Updates: February 2018

Using NCI Controlled Terminology for Standardizing Data

Using SDTM, ADaM and SEND for Regulatory Submissions

Using Define-XML for Dataset Design

Using ODM and CDASH for CRF Design

An Introduction to CDISC Standards

How To Handle Skipped Questions in SDTM QS Domains

Standardized data - The industry is struggling

The Twelve Days of Formedix

When Should I Use CDISC SDTM v1.5?

Sharing of Data from Clinical Trials

CDISC UK Network Update Q3 2016

CDISC Define-XML 1.0 Comes to the End of its Life

A Unique Proposition for the Outsourcing Market

In the News: Standardized Submissions — Are You Prepared?

Saving Lives, Time and Money At The Same Time

The Monday Morning Briefing: Biotech Bubble Debate Rumbles On

Controlled Terminology and CDASH

The Tuesday Morning Briefing: FDA Bruised but Cruising after Bad News Week

Eh... What's SUPPQUAL? An Introduction to Supplemental Qualifiers

The Monday Morning Briefing: Nobel Prize Goes to Pioneering Parasitic Disease Researchers

9 SDTM Mapping Scenarios to Master

Homegrown Define-XML vs. Automated Define-XML

SDTM and Define-XML: Two Separate Standards

The Monday Morning Briefing: Major Blood Pressure Trial Halted Early

Paperless Clinical Trials: How Far Away Are We?

The Monday Morning Briefing: Approvals galore - a busy week for the FDA

3 Things You Should Know About the Analysis Data Model (ADaM)

The Monday Morning Briefing: Amgen's new cholesterol drug gets green light

Optimizing an End-to-End Clinical Trial in 3 Steps

The Monday Morning Briefing: Valeant buys "Female Viagra" maker

EudraCT: An Introduction to the European Clinical Trials Database

The Monday Morning Briefing: Kim Kardashian endorsement lands drugmaker FDA warning

5 Talking Points from the Japanese CDISC Blueprint

The Monday Morning Briefing: Pfizer first with positive "immune accelerator" results

Instant gratification is everywhere. Are clinical trials ready?

The Monday Morning Briefing: Ebola vaccine "100 percent successful" in trials

The Monday Morning Briefing: Allergan offloads generics division

Who Converts Wins: How to create Define-XML from SAS XPT datasets

The Monday Morning Briefing: FDA and Google discuss mining side effect search data

The Tuesday Morning Briefing: Apple's ResearchKit to become a feature in clinical trials?

Formedix #DIA2015 Interviews: The End of User Licenses: How Formations Could Revolutionize Software Procurement

The Tuesday Morning Briefing: Big pharma will supply Greece, despite crisis

Formedix #DIA2015 Interviews: CDISC Standards Deadline Raises Bar for Japanese Firms

The Monday Morning Briefing: Novartis and Valeant on the acquisition trail

Formedix #DIA2015 Interviews: With On Demand Services, Formedix is Changing the Face of Clinical Trial Automation

The Monday Morning Briefing: Supreme Court to rule on insurance, Teva increases stake in Mylan

The Monday Morning Briefing: DIA week kicks off with bumper news from J&J, Lilly and AstraZeneca

The Monday Morning Briefing: Shire set to acquire Actelion?

The role of the hashtag in #clinicaltrials

The Monday Morning Briefing: potential for multi-billion dollar immunotherapy market excites analysts

The Tuesday Morning Briefing: Pharma exec pay tops charts, Pfizer mulling over next mega-merger

The Monday Morning Briefing: 2015's most influential biotech figures and news from Amgen, Boehringer and more!

The Monday Morning Briefing: GSK plans new HIV research centre

The Monday Morning Briefing: merger madness and FDA updates

The Monday Morning Briefing: A good week for AstraZeneca

The Monday Morning Briefing: UK biotechs safe if bubble bursts, Shire shares surge

The Tuesday Morning Briefing: News from Novartis, Bristol, Shire and Pfizer

15 Changes in Clinical Trials Since 2000: Part 3

The Monday Morning Briefing: Ebola report criticizes governments, US biotech

15 Changes in Clinical Trials Since 2000: Part 2

The Monday Morning Briefing: Google's genetic testing firm sets sights on novel drugs, excitement as new era of heart drugs looms

15 Changes in Clinical Trials Since 2000: Part 1

The Monday Morning Briefing: The FDA makes history, flexes its muscles and takes an approval on the chin

The Monday Morning Briefing: Asset Swaps, New Chairmen and Federal Citations

Monday Morning Briefing: New CEO for Sanofi as Superbug Debate Spreads

New AstraZeneca link takes off, calls for ALS drug to be fast-tracked

Pfizer & AstraZeneca in new deals, FDA chief steps down

Actavis Acquires Auden and Spark IPO Blows Up

The Monday Morning Briefing: Will Marijuana be reclassified for new research?

Mark Wheeldon Discusses CDISC Standards From the Start: Part 2

The Monday Morning Briefing: GSK, Biotech Booms and Jetlag Cures

Mark Wheeldon Discusses CDISC Standards From the Start - Part 1

The Monday Morning Briefing: Takeovers Make a Comeback

The Monday Morning Briefing: FDA, Ebola, J&J and more

The Monday Morning Briefing: AbbVie, Cubist, Roche and more

Our Clinical Trial Predictions For 2015

The Monday Morning Briefing: Roche, patent laws and financial fallout

5 Things You Didn't Know Define-XML Could Do

The Monday Morning Briefing: Latest news on Merck, Roche and Genentech

The Monday Morning Briefing: the week's pharma news, digested.

Five Things We're Thankful For in 2014

The Monday Morning Briefing - breaking pharma news

The Monday Morning Briefing - today's essential pharma news

The Monday Morning Briefing - the week's pharma news in one place

Monday Morning Briefing - essential pharma news, digested

The Monday Morning Briefing - the week's pharma news, digested

The Monday Morning Briefing: Ebola special report

The Monday Morning Briefing: breaking pharma news and features

Annotation Frustration: The pitfalls of non-CDISC CRFs

The Monday Morning Briefing: the week's pharma news, digested.

The Monday Morning Briefing: breaking pharma news and features

Monday Morning Briefing: five pharma stories you need to read

Monday Morning Briefing: the pharma news you need to know

Breaking News from the Pharma Industry this Tuesday!

DIA 2014 Sessions: The Evaluation Results are in!

Monday Morning Briefing: news from across the pharma world

Four things we learned at CDISC Asia/Japan Interchange 2014

Monday Morning Briefing: today's top pharma news stories

Monday Morning Briefing: five pharma news stories you need to know about

Meet the five innovators who are changing the clinical trials landscape

Outsourcing will change the way organizations think about data, says Formedix CEO - video

Fast and Flexible Standards with CDISC

Optimizing Both New and Legacy Studies with CDISC

Big Data to Improve ClinicalTrials.gov

Making Life as a CRO Simpler

Vote for Mark Wheeldon: The Clinical People’s Choice

What can be achieved with CDISC ODM? Standardized libraries of content are just the beginning...

It's time to SHARE!

Tracking the evolution of CDISC SDTM

Transform for OpenClinica - all you need to know!

Life Science Events. In person or virtual; what works best for you?

Rave? OpenClinica? Migrating studies between EDCs isn't so tough...

Sit down to a Christmas blog with Formedix!

Break free from XPT files with CDISC Study Dataset-XML

Social Media: Just for the ‘Cooler Kids’ than us in Pharma and Life Sciences?

Christmas Time with the Formedix Team

5 Reasons to be Thankful this Thanksgiving

'CRO industry revenue expected to double'...will you be part of it?

The word on the street is CDISC...

4 Compelling Reasons to Take the CDISC Journey.

How to Plan for Controlled Terminology

Is the Increasing Wave of External Standards Threatening to Drown You?